Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1.
Miyauchi T, Kanda T, Imazeki F, Mikata R, Tawada A, Arai M, Fujiwara K, Nakamoto S, Wu S, Tanaka T, Miyamura T, Kimura M, Hirai Y, Takashi M, Mikami S, Sugiura N, Natsuki Y, Azemoto R, Suzuki N, Yokosuka O. Miyauchi T, et al. Among authors: takashi m. Hepatol Int. 2013 Mar;7(1):144-52. doi: 10.1007/s12072-012-9349-4. Epub 2012 Feb 10. Hepatol Int. 2013. PMID: 26201628
Response to peginterferon-alfa 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 2.
Kanda T, Imazeki F, Azemoto R, Yonemitsu Y, Mikami S, Kita K, Takashi M, Sunaga M, Wu S, Nakamoto S, Tawada A, Arai M, Kato K, Yoshida Y, Koma Y, Fujiwara K, Fukai K, Suzuki N, Yokosuka O. Kanda T, et al. Among authors: takashi m. Dig Dis Sci. 2011 Nov;56(11):3335-42. doi: 10.1007/s10620-011-1750-7. Epub 2011 May 22. Dig Dis Sci. 2011. PMID: 21604145
High sustained virologic response rate after interferon monotherapy in Japanese hepatitis C patients with a low HCV RNA titer and/or HCV genotype 2. A prospective study.
Yokosuka O, Iwama S, Suzuki N, Takashi M, Hirai Y, Uchiumi K, Kimura M, Gotou N, Hino S, Hayasaka A, Kanda T, Kawai S, Fukai K, Imazeki F, Saisho H. Yokosuka O, et al. Among authors: takashi m. Intervirology. 2004;47(6):328-34. doi: 10.1159/000080876. Intervirology. 2004. PMID: 15564744 Clinical Trial.
Occurrence of hepatocellular carcinoma was not a rare event during and immediately after antiviral treatment in Japanese HCV-positive patients.
Kanda T, Imazeki F, Mikami S, Kato K, Shimada N, Yonemitsu Y, Miyauchi T, Arai M, Fujiwara K, Tsubota A, Takada N, Nishino T, Takashi M, Sugiura N, Kimura M, Fukai K, Yokosuka O. Kanda T, et al. Among authors: takashi m. Oncology. 2011;80(5-6):366-72. doi: 10.1159/000330549. Epub 2011 Aug 3. Oncology. 2011. PMID: 21822027 Clinical Trial.
Quantification of hepatitis C virus in patients treated with peginterferon-alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test.
Kanda T, Imazeki F, Yonemitsu Y, Mikami S, Takada N, Nishino T, Takashi M, Tsubota A, Kato K, Sugiura N, Tawada A, Wu S, Tanaka T, Nakamoto S, Mikata R, Tada M, Chiba T, Kurihara T, Arai M, Fujiwara K, Kanai F, Yokosuka O. Kanda T, et al. Among authors: takashi m. J Viral Hepat. 2011 Jul;18(7):e292-7. doi: 10.1111/j.1365-2893.2010.01409.x. Epub 2010 Dec 3. J Viral Hepat. 2011. PMID: 21129130
160 results